Report Detail

Request for Sample of this report

Other Global Latent Tuberculosis Infection (LTBI) Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4529143
    • |
  • 13 April, 2023
    • |
  • Global
    • |
  • 87 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
According to our (Global Info Research) latest study, the global Latent Tuberculosis Infection (LTBI) Testing market size was valued at USD 1436.4 million in 2022 and is forecast to a readjusted size of USD 2043.9 million by 2029 with a CAGR of 5.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
This report is a detailed and comprehensive analysis for global Latent Tuberculosis Infection (LTBI) Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Latent Tuberculosis Infection (LTBI) Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Latent Tuberculosis Infection (LTBI) Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Latent Tuberculosis Infection (LTBI) Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific and Par Sterile and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Market segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Market segment by players, this report covers
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Latent Tuberculosis Infection (LTBI) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Latent Tuberculosis Infection (LTBI) Testing, with revenue, gross margin and global market share of Latent Tuberculosis Infection (LTBI) Testing from 2018 to 2023.
Chapter 3, the Latent Tuberculosis Infection (LTBI) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Latent Tuberculosis Infection (LTBI) Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Latent Tuberculosis Infection (LTBI) Testing.
Chapter 13, to describe Latent Tuberculosis Infection (LTBI) Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Latent Tuberculosis Infection (LTBI) Testing by Type
    • 1.3.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type in 2022
    • 1.3.3 Tuberculin Skin Test (TST)
    • 1.3.4 Interferon Gamma Released Assay (IGRA)
  • 1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application
    • 1.4.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals and Clinics
    • 1.4.3 Diagnostic Laboratories
    • 1.4.4 Others
  • 1.5 Global Latent Tuberculosis Infection (LTBI) Testing Market Size & Forecast
  • 1.6 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Region
    • 1.6.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region, (2018-2029)
    • 1.6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Qiagen
    • 2.1.1 Qiagen Details
    • 2.1.2 Qiagen Major Business
    • 2.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
    • 2.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Qiagen Recent Developments and Future Plans
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
    • 2.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Sanofi Recent Developments and Future Plans
  • 2.3 Oxford Immunotec
    • 2.3.1 Oxford Immunotec Details
    • 2.3.2 Oxford Immunotec Major Business
    • 2.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
    • 2.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Oxford Immunotec Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 Par Sterile
    • 2.5.1 Par Sterile Details
    • 2.5.2 Par Sterile Major Business
    • 2.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
    • 2.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Par Sterile Recent Developments and Future Plans
  • 2.6 Bio-Rad Laboratories
    • 2.6.1 Bio-Rad Laboratories Details
    • 2.6.2 Bio-Rad Laboratories Major Business
    • 2.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
    • 2.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Latent Tuberculosis Infection (LTBI) Testing by Company Revenue
    • 3.2.2 Top 3 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2022
    • 3.2.3 Top 6 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2022
  • 3.3 Latent Tuberculosis Infection (LTBI) Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Latent Tuberculosis Infection (LTBI) Testing Market: Region Footprint
    • 3.3.2 Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Type Footprint
    • 3.3.3 Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
  • 6.2 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
  • 6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
    • 6.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
  • 7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
  • 7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
    • 7.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 7.3.3 France Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
    • 8.3.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2018-2029)
    • 8.3.2 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 8.3.5 India Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
  • 9.2 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
  • 9.3 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
    • 9.3.1 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
    • 10.3.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
  • 11.2 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
  • 11.3 Latent Tuberculosis Infection (LTBI) Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain
  • 12.2 Latent Tuberculosis Infection (LTBI) Testing Upstream Analysis
  • 12.3 Latent Tuberculosis Infection (LTBI) Testing Midstream Analysis
  • 12.4 Latent Tuberculosis Infection (LTBI) Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Latent Tuberculosis Infection (LTBI) Testing. Industry analysis & Market Report on Latent Tuberculosis Infection (LTBI) Testing is a syndicated market report, published as Global Latent Tuberculosis Infection (LTBI) Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Latent Tuberculosis Infection (LTBI) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,752.68
    		4,129.02
    		5,505.36
    		3,208.56
    		4,812.84
    		6,417.12
    		540,444.00
    		810,666.00
    		1,080,888.00
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo